Manier, S., Dimopoulos, M.-A., Leleu, X. P., Moreau, P., Cavo, M., Goldschmidt, H., Orlowski, R. Z., Tron, M., Tekle, C., Brégeault, M.-F., Shafer, A. T., Beksac, M. and Facon, T. (2025) “Isatuximab plus bortezomib, lenalidomide, and dexamethasone for transplant-ineligible newly diagnosed multiple myeloma patients: a frailty subgroup analysis of the IMROZ trial”, Haematologica. Pavia, Italy, 110(9), pp. 2139-2150. doi: 10.3324/haematol.2024.287200.